logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
N

Novartis Ireland Limited

Scholars5
Papers6
Citations0
Related Papers (6)
Publication Date
delete
Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2
errannals of allergy, asthma & immunology
IF0
err2026-06-15
err0
PREAI
errGiselle Mosnaim; Sarbjit Saini; Mark Lebwohl; Simon F. Thomsen; John Reed; Bin Yang; Atsushi Fukunaga; Vipul Jain; Clarice Field; Merin Kuruvilla; El-Djouher Martzloff; Noriko Seko; Pengpeng Wang; Sibylle Haemmerle; Martin Metz
errShare
errSave
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma
errCancer
IF5.1
err2026-03-25
err0
PREAI
errFredrik Schjesvold MD, PhD; Andrew Spencer MBBS, FRACP, FRCPA, DM; Yael C. Cohen MD; Enrique M. Ocio MD, PhD; Jordi Lopez-Pardo MD; Anna Maria Cafro MD; Natalie S. Callander MD; Jonathan L. Kaufman MD; Meera Mohan MD, MS; Martin Wermke MD; Noriko Doki PhD, MD; Rebecca Kan MPH; Pedro Milanez-Almeida PhD; Andrew Stein PhD; Gina Trabucco MSc; Stan Ye PhD; Karolina Kulec MSc; Romain Sechaud PhD; Souvik Banerjee PhD; Huiqin Zhong PhD; Clinton Lai MBChB, FFPM; Philipp J. Rauch MD; Marc S. Raab MD
errShare
errSave
Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database
errEuropean Heart Journal
IF35.6
err2025-11-05
err0
PREAI
errH Byrne; S Sinha; H Pradhan; S Roy; M Bhavsar; X Hu; M Costa-Scharplatz; N P Shah
errShare
errSave
Association of elevated lipoprotein(a) with future major adverse cardiovascular events in recurrent ASCVD patients: analysis of a large US electronic health record database
errEuropean Heart Journal
IF35.6
err2025-11-05
err0
PREAI
errH Byrne; S Sinha; H Pradhan; S Roy; M Bhavsar; X Hu; M Costa-Scharplatz; N P Shah
errShare
errSave
Remibrutinib in chronic spontaneous urticaria: 52-Week results from two phase 3 studies
errJournal of Allergy and Clinical Immunology
IF11.2
err2025-10-18
err0
PREAI
errAna Maria Giménez-Arnau; Robert Szalewski; Michihiro Hide; Vipul Jain; Abdallah Khemis; Mark Lebwohl; Martin Metz; Giselle Mosnaim; Michael Palumbo; Ekin Şavk; Gordon Sussman; Irena Walecka-Herniczek; Bin Yang; Claire Field; Sibylle Haemmerle; Karine Lheritier; Paula G.P. Machado; El-Djouher Martzloff; Noriko Seko; Pengpeng Wang; Artem Zharkov; Sarbjit Saini
errShare
errSave
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis
errBlood Advances
IF7.1
err2025-05-09
err0
errOAAI
errDavid M. Ross; Florian H. Heidel; Andrew Charles Perkins; Andreas Reiter; Carl Crodel; Caroline Riley; María Teresa Gómez-Casares; Istvan Takacs; Heiko Becker; Thomas Lehmann; Olga Vinogradova; Kate Burbury; Alessandro M. Vannucchi; Vikas Gupta; Marielle Wondergem; Jean-Jacques Kiladjian; Grace Cleary; Angela Zhang; Jagannath Kota; Anirudh Prahallad; Monika Wroclawska; Min Lu; Claire N. Harrison
errShare
errSave